Summary of Classification and Labelling
Notified classification and labelling
General Information
813-745-9 |
S-[(2R,3S,4S,6S)-6-[[(2R,3S,4S,5R,6R)-5-[(2S,4S,5S)-5-(ethylamino)-4-methoxyoxan-2-yl]oxy-4-hydroxy-6-[[(2S,5Z,9R,13Z)-9-hydroxy-12-(methoxycarbonylamino)-13-[2-(methyltrisulfanyl)ethylidene]-11-oxo-2-bicyclo[7.3.1]trideca-1(12),5-dien-3,7-diynyl]oxy]-2-methyloxan-3-yl]amino]oxy-4-hydroxy-2-methyloxan-3-yl] 4-[(2S,3R,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5-iodo-2,3-dimethoxy-6-methylbenzenecarbothioate |
108212-75-5 |
Notified classification and labelling according to CLP criteria
Acute Tox. 4 |
H302
|
H302
|
|
GHS07 GHS08 Dgr
|
|
|
|
|
1 |
|
View details
|
Muta. 2 |
H341
|
H341
|
Repr. 2 |
H361
|
H361
|
STOT RE 1 |
H372
(organs)
(inhalation,oral)
|
H372
|
Number of Aggregated Notifications: 1